WT1 and non-small cell lung carcinoma: These findings indicate that SNRPG negatively regulates the protein level of WT1 through directly binding to WT1, thereby weakening the transcriptional activation effect on the CDK14 promoter, and ultimately inhibiting the migration, invasion, EMT and metastasis of NSCLC cells.